Source & methodology
Why this tool, and where the numbers come from.
The Menopause Rating Scale (MRS) was first published in 1996 by the Berlin Center for Epidemiology and Health Research as a way to measure how badly menopause symptoms affect a woman's life. It has since been validated in dozens of countries and translated into over 25 languages. It is one of the most widely used menopause symptom scales in clinical research and in real-world OB-GYN practice.
The 11 questions on this page are the standard MRS items, rewritten in plain English so you don't need a medical dictionary. Each item is rated 0 to 4. The total score (0-44) and the three subscale scores (physical, mental, sexual/urinary) match the published instrument exactly. Severity tiers come from the validation literature:
- 0-4: None to very mild
- 5-8: Mild
- 9-15: Moderate
- 16+: Severe
The treatment guidance reflects the 2022 NAMS Hormone Therapy Position Statement, which supports HRT for healthy women under 60 (and within 10 years of menopause) whose symptoms are bothersome. NAMS is the major North American clinical society for menopause medicine.
Citations
- Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003;1:28. View paper →
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. View statement →
Disclaimer. This calculator is a symptom-tracking tool, not a medical diagnosis. It does not replace a conversation with a licensed doctor. ClearedRx's Medical Network — board-certified MDs licensed in all 50 states — reviews each patient's intake before any prescription is written.